How do I treat a small triangular opacity akin to an anterior oblique fissure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Small Triangular Opacity Adjacent to Anterior Oblique Fissure

No treatment is required for small triangular opacities adjacent to pulmonary fissures when they demonstrate characteristic benign morphology consistent with intrapulmonary lymph nodes or perifissural nodules. 1

Diagnostic Characterization

The key to management is proper radiographic characterization on CT imaging:

Benign Features (No Follow-up Required)

  • Triangular or oval shape on transverse images with flat or lentiform configuration on sagittal/coronal reconstructions 1
  • Location within 1 cm of a fissure (perifissural) or adjacent to pleural surface (subpleural) 1
  • Fine linear septal extension to the pleura 1
  • Smooth, homogeneous appearance without spiculation 1

When these morphologic criteria are met, follow-up CT is not recommended even if the average dimension exceeds 6 mm. 1 In the NELSON Lung Cancer Screening Trial, 20% of nodules were classified as perifissural, and while 16% grew during follow-up, none were malignant 1.

Features Requiring Surveillance

Certain characteristics override the benign perifissural location and mandate follow-up CT in 6-12 months: 1

  • Spiculated borders
  • Displacement of the adjacent fissure
  • History of malignancy
  • Lack of characteristic triangular/lentiform morphology

Imaging Recommendations

Initial Assessment

  • Review on coronal and sagittal reconstructed images to confirm the elongated, triangular configuration that distinguishes benign scars from true nodules 1
  • Use contiguous thin-section CT (≤2 mm collimation) for accurate characterization 1
  • Measure using average of long- and short-axis diameters rounded to the nearest millimeter 1

When Imaging is Incomplete

For opacities detected on incomplete thoracic CT scans (neck, cardiac, or abdominal studies): 1

  • <6 mm: No further investigation recommended
  • 6-8 mm: Follow-up complete chest CT after 3-12 months depending on clinical risk factors
  • >8 mm or suspicious features: Proceed with complete thoracic CT examination

Common Pitfalls to Avoid

Do not confuse with apical scarring: Pleural and subpleural apical scarring is extremely common and may appear nodular on transverse images. Look for pleural-based configuration, straight or concave margins, and presence of similar adjacent opacities. 1

Do not rely solely on transverse images: The triangular/lentiform shape that confirms benign perifissural nodules is best appreciated on coronal or sagittal reconstructions. 1

Do not apply volumetry thresholds: While perifissural nodules can be excluded from follow-up even when >6 mm in diameter, this applies only when the specific morphologic criteria are met—not simply based on size or volume measurements. 1

Risk Stratification Context

For nodules that do not meet benign perifissural criteria, management depends on size and clinical risk factors: 1

  • ≤6 mm in low-risk patients: No routine follow-up
  • 6-8 mm: Follow-up CT at 6-12 months based on risk factors (age, smoking history, upper lobe location)
  • >8 mm: Consider PET-CT or biopsy depending on clinical context

The critical distinction is that true perifissural nodules with characteristic morphology bypass this algorithm entirely and require no follow-up regardless of size. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.